‹ All Posts
SFP RESEARCH

3rd May 2025 · SEBI-Registered Analyst

CONCORD BIOTECH

CONCORD BIOTECH; USFDA Completes Concord Biotech’s Dholka Plant Inspection with 4 Observations USFDA inspection from April 28 to May 2, 2025. Issued Form 483 with 4 procedural observations, no data integrity issues. Concord to submit response and expects quick resolution

#StockInNews#WatchOutFor#FundamentalViews#EquityResearch#PersonalFinance
101 likes·57 comments